-
February 20, 2007 Lupin sells Intellectual Property on Perindopril to Servier
-
February 7, 2007 Lupin receives US FDA approval for Sertraline
-
January 19, 2007 Lupin and Aspen decide not to pursue their MOU
-
January 17, 2007 Lupin FY 2006-07 Q3 Net Profit up by 27% at Rs.560 mn
-
January 2, 2007 Lupin gets tentative US FDA approval for Sertraline
-
December 27, 2006 Lupin and Cornerstone End Development Agreement
-
December 25, 2006 Lupin’s US Subsidiary and Chester Valley Pharmaceuticals decide to end promotion agreement
-
December 19, 2006 Lupin gets tentative US FDA approval for Trandolapril
-
December 7, 2006 Lupin gets DCGI approval to conduct Phase III clinical trials for Migraine NCE
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications